CHINA TOPIX

12/23/2024 02:54:36 am

Make CT Your Homepage

Amgen

Amgen Announces BLINCYTO A Successful Drug For Leukemia

Amgen Announces BLINCYTO A Successful Drug For Leukemia In Phase 2 Trial

BLINCYTO, a drug for relapsed or refractory Philadelphia chromosome-positive (Ph+) B-cell precursor acute lymphoblastic leukemia, was found to be a great success in phase 2 trials, announced Amgen on Thursday, July 16.

Chemotherapy

Cancer Is No Longer the Formidable Illness It Used to Be

A lot has changed since the '70s, an era when cancer cure could be labelled as 'inchoate.' Indeed, there was a serious stance on battling cancer at the time, but results were always meagre and far from stunning.

Real Time Analytics